ARDELYX, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| MOTT DAVID M | — | Purchase | 213,300 | $4.67 | $996,111 | 1,638,765 | Dec 19, 2024 |
| RAAB MICHAEL | President & CEO | Option Exercise | 25,000 | $0.99 | $24,750 | 1,175,385 | Dec 10, 2024 |
| RAAB MICHAEL | President & CEO | Sale | 25,000 | $5.38 | $134,500 | 1,150,385 | Nov 25, 2024 |
| Williams Laura A | Chief Medical Officer | Sale | 7,366 | $4.79 | $35,283 | 308,745 | Nov 20, 2024 |
| Rosenbaum David P. | Chief Development Officer | Sale | 2,243 | $4.79 | $10,744 | 151,373 | Nov 20, 2024 |
| Renz Justin A | Chief Financial Officer | Sale | 5,260 | $4.79 | $25,195 | 291,139 | Nov 20, 2024 |
| RAAB MICHAEL | President & CEO | Sale | 31,980 | $4.79 | $153,184 | 1,175,385 | Nov 20, 2024 |
| GRAMMER ELIZABETH A | See Remarks | Sale | 7,046 | $4.79 | $33,750 | 185,334 | Nov 20, 2024 |
| Blanks Robert | See Remarks | Sale | 4,941 | $4.79 | $23,667 | 314,421 | Nov 20, 2024 |
| MOTT DAVID M | — | Purchase | 215,868 | $4.62 | $997,310 | 1,425,465 | Nov 13, 2024 |
| RAAB MICHAEL | President & CEO | Sale | 2,743 | $4.90 | $13,441 | 1,207,365 | Nov 11, 2024 |
| Rosenbaum David P. | Chief Development Officer | Sale | 27,171 | $6.10 | $165,743 | 153,616 | Nov 6, 2024 |
| Rosenbaum David P. | Chief Development Officer | Option Exercise | 27,172 | $2.32 | $63,039 | 180,788 | Nov 4, 2024 |
| RAAB MICHAEL | President & CEO | Sale | 25,000 | $5.91 | $147,750 | 1,210,108 | Oct 28, 2024 |
| RAAB MICHAEL | President & CEO | Sale | 7,500 | $6.01 | $45,075 | 1,210,108 | Oct 11, 2024 |
| Rosenbaum David P. | Chief Development Officer | Sale | 49,564 | $6.92 | $342,983 | 301,946 | Sep 27, 2024 |
| RAAB MICHAEL | President & CEO | Sale | 3,000 | $6.07 | $18,210 | 1,217,608 | Sep 26, 2024 |
| Rosenbaum David P. | Chief Development Officer | Sale | 5,312 | $6.26 | $33,253 | 153,616 | Sep 13, 2024 |
| RAAB MICHAEL | President & CEO | Sale | 35,000 | $5.61 | $196,350 | 1,220,608 | Sep 11, 2024 |
| RAAB MICHAEL | President & CEO | Sale | 7,500 | $6.22 | $46,650 | 1,219,509 | Aug 27, 2024 |
| Williams Laura A | Chief Medical Officer | Sale | 7,412 | $5.86 | $43,434 | 314,740 | Aug 20, 2024 |
| Rosenbaum David P. | Chief Development Officer | Sale | 2,250 | $5.86 | $13,185 | 156,252 | Aug 20, 2024 |
| Renz Justin A | Chief Financial Officer | Sale | 5,289 | $5.86 | $30,994 | 295,257 | Aug 20, 2024 |
| RAAB MICHAEL | President & CEO | Sale | 32,225 | $5.86 | $188,839 | 1,227,009 | Aug 20, 2024 |
| GRAMMER ELIZABETH A | See Remarks | Sale | 7,089 | $5.86 | $41,542 | 192,380 | Aug 20, 2024 |
| Felsch Robert Ora | See Remarks | Sale | 3,567 | $5.86 | $20,903 | 91,560 | Aug 20, 2024 |
| Blanks Robert | See Remarks | Sale | 4,969 | $5.86 | $29,118 | 319,362 | Aug 20, 2024 |
| Rosenbaum David P. | Chief Development Officer | Option Exercise | 20,507 | $0.99 | $20,302 | 179,009 | Aug 20, 2024 |
| RAAB MICHAEL | President & CEO | Sale | 1,229 | $5.71 | $7,018 | 1,259,234 | Aug 12, 2024 |
| Foster Eric Duane | Chief Commercial Officer | Award / Grant | 180,000 | — | — | 180,000 | Aug 8, 2024 |
| RAAB MICHAEL | President & CEO | Option Exercise | 30,000 | $0.99 | $29,700 | 1,290,463 | Jul 29, 2024 |
| RAAB MICHAEL | President & CEO | Sale | 7,500 | $5.97 | $44,775 | 1,260,463 | Jul 15, 2024 |
| RAAB MICHAEL | President & CEO | Sale | 2,310 | $6.59 | $15,223 | 1,267,963 | Jun 28, 2024 |
| Blanks Robert | See Remarks | Sale | 38,000 | $5.96 | $226,480 | 324,331 | Jun 21, 2024 |
| Rodgers Richard J | — | Award / Grant | 12,204 | — | — | 250,524 | Jun 14, 2024 |
| Bertrand William C JR | — | Award / Grant | 11,023 | — | — | 229,766 | Jun 14, 2024 |
| MOTT DAVID M | — | Award / Grant | 17,322 | — | — | 1,209,597 | Jun 14, 2024 |
| RAAB MICHAEL | President & CEO | Option Exercise | 35,000 | $0.99 | $34,650 | 1,305,273 | Jun 13, 2024 |
| Williams Laura A | Chief Medical Officer | Sale | 45,000 | $7.12 | $320,400 | 422,152 | Jun 5, 2024 |
| Rosenbaum David P. | Chief Development Officer | Sale | 17,872 | $7.00 | $125,104 | 158,502 | Jun 3, 2024 |
| RAAB MICHAEL | President & CEO | Sale | 7,500 | $6.72 | $50,400 | 1,270,273 | May 29, 2024 |
| Williams Laura A | Chief Medical Officer | Sale | 4,794 | $7.81 | $37,441 | 367,152 | May 21, 2024 |
| Rosenbaum David P. | Chief Development Officer | Sale | 2,198 | $7.81 | $17,166 | 176,374 | May 21, 2024 |
| Rodriguez Susan | Chief Commercial Officer | Sale | 6,703 | $7.81 | $52,350 | 449,092 | May 21, 2024 |
| Renz Justin A | Chief Financial Officer | Sale | 5,167 | $7.81 | $40,354 | 300,546 | May 21, 2024 |
| RAAB MICHAEL | President & CEO | Sale | 31,484 | $7.81 | $245,890 | 1,277,773 | May 21, 2024 |
| GRAMMER ELIZABETH A | See Remarks | Sale | 6,927 | $7.81 | $54,100 | 199,469 | May 21, 2024 |
| Felsch Robert Ora | See Remarks | Sale | 3,485 | $7.81 | $27,218 | 95,127 | May 21, 2024 |
| Blanks Robert | See Remarks | Sale | 4,855 | $7.81 | $37,918 | 362,331 | May 21, 2024 |
| RAAB MICHAEL | President & CEO | Sale | 3,000 | $7.99 | $23,970 | 1,307,933 | May 14, 2024 |